CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | Shiver John W. Director | Grant or award · Restricted Stock Units | +23,840 | 23,840 | ||
| 2025-03-07 | Trizzino John President and COO | Option exercise | +28,890 | 82,015 | ||
| 2025-03-07 | Trizzino John President and COO | Shares withheld for taxes | −13,954 | $8.34 | $116K | 68,061 |
| 2025-03-07 | Trizzino John President and COO | Option exercise · Restricted Stock Units | −28,890 | 28,890 | ||
| 2025-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise | +12,223 | 75,155 | ||
| 2025-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Shares withheld for taxes | −5,904 | $8.34 | $49K | 69,251 |
| 2025-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise · Restricted Stock Units | −12,223 | 12,223 | ||
| 2025-03-03 | Casey Mark J EVP, Chief Legal Officer | Grant or award · 2025 Non-statutory Stock Option NQ | +169,000 | $7.87 | $1.3M | 169,000 |
| 2025-03-03 | Casey Mark J EVP, Chief Legal Officer | Grant or award · 2025 Restricted Stock Units RSU | +112,500 | 112,500 | ||
| 2025-03-03 | Draghia-Akli Ruxandra Section 16 | Grant or award · 2025 Non-statutory Stock Option NQ | +120,000 | $7.87 | $944K | 120,000 |
| 2025-03-03 | Draghia-Akli Ruxandra Section 16 | Grant or award · 2025 Restricted Stock Units RSU | +80,000 | 80,000 | ||
| 2025-03-03 | Jacobs John C President and CEO | Grant or award · 2025 Non-statutory Stock Option NQ | +676,000 | $7.87 | $5.3M | 676,000 |
| 2025-03-03 | Jacobs John C President and CEO | Grant or award · 2025 Restricted Stock Units RSU | +450,500 | 450,500 | ||
| 2025-03-03 | O'Hara Elaine EVP, Chief Strategy Officer | Grant or award · 2025 Non-statutory Stock Option NQ | +253,500 | $7.87 | $2.0M | 253,500 |
| 2025-03-03 | O'Hara Elaine EVP, Chief Strategy Officer | Grant or award · 2025 Restricted Stock Units RSU | +169,000 | 169,000 | ||
| 2025-03-03 | Kelly James Patrick EVP, CFO and Treasurer | Grant or award · 2025 Non-statutory Stock Option NQ | +194,500 | $7.87 | $1.5M | 194,500 |
| 2025-03-03 | Kelly James Patrick EVP, CFO and Treasurer | Grant or award · 2025 Restricted Stock Units RSU | +129,500 | 129,500 | ||
| 2025-03-01 | Trizzino John President and COO | Option exercise | +48,000 | 76,310 | ||
| 2025-03-01 | Trizzino John President and COO | Shares withheld for taxes | −23,185 | $8.33 | $193K | 53,125 |
| 2025-03-01 | Trizzino John President and COO | Option exercise · Restricted Stock Units | −48,000 | 96,000 |
Page 7 of 14 · 279 trades